Research progamme: antibody-drug conjugates - PhotoBiotics/Quassia Biopharma
Latest Information Update: 11 Aug 2016
At a glance
- Originator PhotoBiotics
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Photosensitisers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 28 Jul 2016 Early research in Undefined indication in United Kingdom (Parenteral)